These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 2046344

  • 1. Urinary screening for midazolam and its major metabolites with the Abbott ADx and TDx analyzers and the EMIT d.a.u. benzodiazepine assay with confirmation by GC/MS.
    Fraser AD, Bryan W, Isner AF.
    J Anal Toxicol; 1991; 15(1):8-12. PubMed ID: 2046344
    [Abstract] [Full Text] [Related]

  • 2. Urinary screening for alprazolam and its major metabolites by the Abbott ADx and TDx analyzers with confirmation by GC/MS.
    Fraser AD, Bryan W, Isner AF.
    J Anal Toxicol; 1991; 15(1):25-9. PubMed ID: 2046338
    [Abstract] [Full Text] [Related]

  • 3. Urinary screening for alpha-OH triazolam by FPIA and EIA with confirmation by GC/MS.
    Fraser AD, Bryan W, Isner AF.
    J Anal Toxicol; 1992; 16(6):347-50. PubMed ID: 1293398
    [Abstract] [Full Text] [Related]

  • 4. Urinary screening for adinazolam and its major metabolites by the Emit d.a.u. and FPIA benzodiazepine assays with confirmation by HPLC.
    Fraser AD, Isner AF, Bryan W.
    J Anal Toxicol; 1993; 17(7):427-31. PubMed ID: 8309217
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the Abbott ADx and TDx serum benzodiazepine immunoassays for analysis of alprazolam.
    Fraser AD, Bryan W.
    J Anal Toxicol; 1991; 15(2):63-5. PubMed ID: 1675703
    [Abstract] [Full Text] [Related]

  • 6. New fluorescence polarization immunoassays for analysis of barbiturates and benzodiazepines in serum and urine: performance characteristics.
    Schwenzer KS, Pearlman R, Tsilimidos M, Salamone SJ, Cannon RC, Wong SH, Gock SB, Jentzen JJ.
    J Anal Toxicol; 2000; 24(8):726-32. PubMed ID: 11110029
    [Abstract] [Full Text] [Related]

  • 7. Urinary screening for alprazolam, triazolam, and their metabolites with the EMIT d.a.u. benzodiazepine metabolite assay.
    Fraser AD.
    J Anal Toxicol; 1987; 11(6):263-6. PubMed ID: 3323671
    [Abstract] [Full Text] [Related]

  • 8. Identification of urinary benzodiazepines and their metabolites: comparison of automated HPLC and GC-MS after immunoassay screening of clinical specimens.
    Valentine JL, Middleton R, Sparks C.
    J Anal Toxicol; 1996 Oct; 20(6):416-24. PubMed ID: 8889678
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the Abbott ADx Amphetamine/Methamphetamine II abused drug assay: comparison to TDx, EMIT, and GC/MS methods.
    Przekop MA, Manno JE, Kunsman GW, Cockerham KR, Manno BR.
    J Anal Toxicol; 1991 Oct; 15(6):323-6. PubMed ID: 1779660
    [Abstract] [Full Text] [Related]

  • 10. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off values.
    Fraser AD, Meatherall R.
    J Anal Toxicol; 1996 Oct; 20(4):217-23. PubMed ID: 8835658
    [Abstract] [Full Text] [Related]

  • 11. Abbott phencyclidine and barbiturates abused drug assays: evaluation and comparison of ADx FPIA, TDx FPIA, EMIT, and GC/MS methods.
    Caplan YH, Levine B.
    J Anal Toxicol; 1989 Oct; 13(5):289-92. PubMed ID: 2693834
    [Abstract] [Full Text] [Related]

  • 12. Comparison of fluorescence polarization immunoassay, enzyme immunoassay, and thin-layer chromatography for urine cannabinoid screening. Effects of analyte adsorption and vigorous mixing of specimen on detectability.
    Dextraze P, Griffiths WC, Camara P, Audette L, Rosner M.
    Ann Clin Lab Sci; 1989 Oct; 19(2):133-8. PubMed ID: 2546480
    [Abstract] [Full Text] [Related]

  • 13. Application of the Syva EMIT and Abbott TDx amphetamine immunoassays to the detection of 3,4-methylene-dioxymethamphetamine (MDMA) and 3,4-methylene-dioxyethamphetamine (MDEA) in urine.
    Kunsman GW, Manno JE, Cockerham KR, Manno BR.
    J Anal Toxicol; 1990 Oct; 14(3):149-53. PubMed ID: 1973747
    [Abstract] [Full Text] [Related]

  • 14. Benzodiazepines identified by capillary gas chromatography-mass spectrometry, with specific ion screening used to detect benzophenone derivatives.
    Jones CE, Wians FH, Martinez LA, Merritt GJ.
    Clin Chem; 1989 Jul; 35(7):1394-8. PubMed ID: 2667799
    [Abstract] [Full Text] [Related]

  • 15. Investigation into some aspects of EMIT d.a.u., TLC, and GC-MS urinalysis of bromazepam.
    El-Haj BM, Al-Amri AM, Hassan MH, Bin-Khadem RK.
    J Anal Toxicol; 2001 Jul; 25(5):316-22. PubMed ID: 11499884
    [Abstract] [Full Text] [Related]

  • 16. Immunoassay detection of benzodiazepines and benzodiazepine metabolites in blood.
    Huang W, Moody DE.
    J Anal Toxicol; 1995 Oct; 19(6):333-42. PubMed ID: 8926726
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of TDx cocaine metabolite assay.
    Poklis A.
    J Anal Toxicol; 1987 Oct; 11(5):228-30. PubMed ID: 3682784
    [Abstract] [Full Text] [Related]

  • 18. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD, Worth D.
    Forensic Sci Int; 2004 Jul 16; 143(2-3):147-52. PubMed ID: 15240035
    [Abstract] [Full Text] [Related]

  • 19. Limitations of EMIT benzodiazepine immunoassay for monitoring compliance of patients with benzodiazepine therapy even after hydrolyzing glucuronide metabolites in urine to increase cross-reactivity: comparison of immunoassay results with LC-MS/MS values.
    Dixon RB, Floyd D, Dasgupta A.
    Ther Drug Monit; 2015 Feb 16; 37(1):137-9. PubMed ID: 25004136
    [Abstract] [Full Text] [Related]

  • 20. Abbott propoxyphene assay: evaluation and comparison of TDx FPIA and GC/MS methods.
    Kintz P, Mangin P.
    J Anal Toxicol; 1993 Feb 16; 17(4):222-4. PubMed ID: 8371551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.